ストックスクリーナーアプリを入手
0.6265
0.35%
-0.0025
Longeveron Inc (LGVN) 最新ニュース
Can Longeveron Inc. stock attract ESG capital inflowsJuly 2025 Technicals & Consistent Profit Trade Alerts - ulpravda.ru
Is Longeveron Inc. stock positioned for long term growthEarnings Growth Report & Daily Price Action Insights - ulpravda.ru
Why Longeveron Inc. stock is considered a top pickJuly 2025 Volume & Consistent Return Strategy Ideas - ulpravda.ru
Will Longeveron Inc. stock continue upward momentumQuarterly Trade Review & Technical Pattern Alert System - ulpravda.ru
Is Longeveron Inc. stock a top momentum play2025 Market Overview & Long-Term Investment Growth Plans - ulpravda.ru
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Longeveron Inc.Class A Common stock (NQ: LGVN - FinancialContent
Longeveron Shares Jump as FDA Clears Phase 2 Trial for Pediatric Heart Therapy - MSN
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026 - marketscreener.com
Alzheimer’s ‘moonshot’ network taps Longeveron to join 2026 founder summit - Stock Titan
Longeveron (NASDAQ:LGVN) Stock Price Down 3.2% – What’s Next? - Defense World
Will Longeveron Inc. stock attract more institutional investors2025 Market WrapUp & Weekly High Conviction Trade Ideas - Улправда
Is Longeveron Stock Built to Withstand More Downside? - Trefis
Comparing Longeveron (NASDAQ:LGVN) & Senti Biosciences (NASDAQ:SNTI) - Defense World
What drives Longeveron Inc stock priceDouble Top/Bottom Patterns & Trusted Financial Advisors at No Cost - earlytimes.in
Longeveron Earnings Notes - Trefis
Is Longeveron Inc. stock a good choice for value investorsNew Guidance & Verified Stock Trade Ideas - Улправда
What risks investors should watch in Longeveron Inc. stockPortfolio Return Summary & Comprehensive Market Scan Reports - DonanımHaber
Why Longeveron Inc. stock remains on watchlists2025 Valuation Update & Technical Confirmation Trade Alerts - DonanımHaber
Is Longeveron Inc. stock a buy in volatile marketsEarnings Trend Report & Precise Swing Trade Alerts - ulpravda.ru
What technical signals suggest for Longeveron Inc. stockEarnings Summary Report & Fast Moving Stock Trade Plans - Улправда
Longeveron receives patent for stem cell therapy targeting female sexual dysfunction - Investing.com Canada
Longeveron granted U.S. patent for method of treating female sexual dysfunction - marketscreener.com
Longeveron receives patent for stem cell therapy targeting female sexual dysfunction By Investing.com - Investing.com South Africa
Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy - The Manila Times
Block Trades: What risks investors should watch in Longeveron Inc stockRate Cut & Free High Return Stock Watch Alerts - moha.gov.vn
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle - The Globe and Mail
Longeveron granted Canadian patent covering laromestrocel administration - MSN
Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN
Prepare Yourself for Liftoff: Longeveron Inc (LGVN) - Setenews
With Longeveron Stock Sliding, Have You Assessed The Risk? - Trefis
Update Recap: Can MCK stock sustain institutional flowsWatch List & Free Weekly Watchlist of Top Performers - BỘ NỘI VỤ
Longeveron executives to speak at CVCT Forum on cell therapy trials - Investing.com Nigeria
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum - The Manila Times
Longeveron (NASDAQ: LGVN) CSO, CMO to Join CVCT Forum Panels on Cell Therapy Trials - Stock Titan
Can Longeveron Inc. stock continue upward trendWeekly Trend Recap & Fast Entry Momentum Alerts - Newser
Longeveron (LGVN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Longeveron receives Canadian patent for stem cell therapy By Investing.com - Investing.com Nigeria
Perhaps timely catching Longeveron Inc (LGVN) would be a good idea - Setenews
Longeveron receives Canadian patent for stem cell therapy - Investing.com
Longeveron granted Canadian patent for method of using stem cells to treat non-ischemic dilated cardiomyopathy - MarketScreener
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging - The Manila Times
Longeveron (NASDAQ: LGVN) gets Canada patent on LOMECEL-B for frailty and NIDCM - Stock Titan
Longeveron’s stem cell therapy shows reduced neuroinflammation in AD trial By Investing.com - Investing.com South Africa
Longeveron to present MRI biomarker data in Alzheimer’s at CTAD 2025 - TipRanks
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) - The Manila Times
Longeveron (NASDAQ: LGVN) sees MRI inflammation drop in 13 of 14 brain regions at week 39 - Stock Titan
0.92%
大文字化:
|
ボリューム (24 時間):